Skip to main content
. 2017 Jul 3;114(10):2328–2338. doi: 10.1002/bit.26346

Figure 5.

Figure 5

Characterization of the binding properties of [3H] DAMGO and [3H]‐Naloxone (NLX) to MOR expressed in HEK 293 cells and MOR expressed in a cell‐free synthesis system. (A) [3H]‐DAMGO saturation binding experiments of HEK MOR and TCF‐MOR in presence of different detergents. (B and C) [3H]‐NLX saturation binding experiments of HEK MOR and TCF‐MOR in the presence of different detergents. (D) [3H]‐DAMGO single point binding experiment of HEK MOR, TCF‐MOR, NCF‐MOR, and NCMF‐MOR (n = 6) presented as counts per minute (cpm). (E) [3H]‐DAMGO single point binding experiment of HEK MOR, TCF‐MOR, NCFMOR, and NCMF‐MOR (n = 6) presented as fmol/mg total protein.